PEPTIDE VACCINES AGAINST INTERLEUKIN-31

A vaccine composition for immunizing and/or protecting a mammal against an IL-31 mediated disorder is provided, wherein the composition includes: the combination of a carrier polypeptide and at least one mimotope selected from a feline IL-31 mimotope, a canine IL-31 mimotope, a horse IL-31 mimotope,...

Full description

Saved in:
Bibliographic Details
Main Authors BAMMERT, GARY FRANCIS, DUNHAM, STEVEN ALAN
Format Patent
LanguageEnglish
French
Published 26.03.2024
Subjects
HUMAN NECESSITIES
HYGIENE
INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIRCHEMICAL OR PHYSICAL PROPERTIES
MEASURING
MEDICAL OR VETERINARY SCIENCE
PHYSICS
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
TESTING
Online AccessGet full text

Cover

More Information
Summary:A vaccine composition for immunizing and/or protecting a mammal against an IL-31 mediated disorder is provided, wherein the composition includes: the combination of a carrier polypeptide and at least one mimotope selected from a feline IL-31 mimotope, a canine IL-31 mimotope, a horse IL-31 mimotope, and a human IL-31 mimotope; and an adjuvant. Such vaccines can be in the form of pharmaceutical compositions useful for treating or protecting mammals such as cats, dogs, horses, or humans against IL-31 -mediated disorders. L'invention concerne une composition de vaccin pour immuniser et/ou protéger un mammifère contre un trouble à médiation par IL-31, la composition comprenant : la combinaison d'un polypeptide porteur et d'au moins un mimotope choisi parmi un mimotope IL-31 félin, un mimotope IL-31 canin, un mimotope IL-31 équin et un mimotope IL-31 humain ; et un adjuvant. Lesdits vaccins peuvent se présenter sous la forme de compositions pharmaceutiques utiles pour traiter ou protéger des mammifères tels que des chats, des chiens, des chevaux ou des êtres humains contre des troubles à médiation par IL-31.
Bibliography:Application Number: CA20193093709